A High-Risk Multiple Myeloma Group Identified By Integrative Multi-Omics Segmentation of Newly Diagnosed Patients

被引：1

作者：

Ortiz, Maria ^{[1
]}

Towfic, Fadi ^{[2
]}

Samur, Mehmet Kemal ^{[3
]}

Flynt, Erin ^{[4
]}

Jang, In Sock ^{[5
]}

Wang, Kai ^{[5
]}

Ashby, Cody ^{[6
]}

Walker, Brian A. ^{[6
]}

Trotter, Matthew ^{[7
]}

Morgan, Gareth ^{[8
]}

Munshi, Nikhil ^{[9
]}

Thakurta, Anjan ^{[2
]}

机构：

[1] CITRE, Res Analyt, Seville, Spain

[2] Celgene Corp, Summit, NJ USA

[3] Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Jerome Lipper Multiple Myeloma Ctr, Boston, MA USA

[4] Celgene Corp, Translat Dev & Diagnost, Summit, NJ USA

[5] Celgene Corp, Res Analyt, San Diego, CA USA

[6] Univ Arkansas Med Sci, Myeloma Inst, Little Rock, AR 72205 USA

[7] CITRE, Seville, Spain

[8] Myeloma Inst Res & Therapy, Little Rock, AR USA

[9] Harvard Med Sch, Dana Farber Canc Inst, LeBow Inst Myeloma Therapeut, Jerome Lipper Multiple Myeloma Ctr,Dept Med Oncol, Boston, MA USA

来源：

BLOOD | 2018年 / 132卷

关键词：

D O I：

10.1182/blood-2018-99-117114

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

3165

引用

页数：2

共 50 条

[1] A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis
Walker, Brian A.
Mavrommatis, Konstantinos
Wardell, Christopher P.
Ashby, T. Cody
Bauer, Michael
Davies, Faith
Rosenthal, Adam
Wang, Hongwei
Qu, Pingping
Hoering, Antje
Samur, Mehmet
Towfic, Fadi
Ortiz, Maria
Flynt, Erin
Yu, Zhinuan
Yang, Zhihong
Rozelle, Dan
Obenauer, John
Trotter, Matthew
Auclair, Daniel
Keats, Jonathan
Bolli, Niccolo
Fulciniti, Mariateresa
Szalat, Raphael
Moreau, Phillipe
Durie, Brian
Stewart, A. Keith
Goldschmidt, Hartmut
Raab, Marc S.
Einsele, Hermann
Sonneveld, Pieter
San Miguel, Jesus
Lonial, Sagar
Jackson, Graham H.
Anderson, Kenneth C.
Avet-Loiseau, Herve
Munshi, Nikhil
Thakurta, Anjan
Morgan, Gareth
LEUKEMIA, 2019, 33 (01) : 159 - 170
[2] A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis
Brian A. Walker
Konstantinos Mavrommatis
Christopher P. Wardell
T. Cody Ashby
Michael Bauer
Faith Davies
Adam Rosenthal
Hongwei Wang
Pingping Qu
Antje Hoering
Mehmet Samur
Fadi Towfic
Maria Ortiz
Erin Flynt
Zhinuan Yu
Zhihong Yang
Dan Rozelle
John Obenauer
Matthew Trotter
Daniel Auclair
Jonathan Keats
Niccolo Bolli
Mariateresa Fulciniti
Raphael Szalat
Phillipe Moreau
Brian Durie
A. Keith Stewart
Hartmut Goldschmidt
Marc S. Raab
Hermann Einsele
Pieter Sonneveld
Jesus San Miguel
Sagar Lonial
Graham H. Jackson
Kenneth C. Anderson
Herve Avet-Loiseau
Nikhil Munshi
Anjan Thakurta
Gareth Morgan
Leukemia, 2019, 33 : 159 - 170
[3] Current Approach to Managing Patients with Newly Diagnosed High-Risk Multiple Myeloma
Naimisha Marneni
Rajshekhar Chakraborty
Current Hematologic Malignancy Reports, 2021, 16 : 148 - 161
[4] Current Approach to Managing Patients with Newly Diagnosed High-Risk Multiple Myeloma
Marneni, Naimisha
Chakraborty, Rajshekhar
CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2021, 16 (02) : 148 - 161
[5] PROGNOSTIC IMPLICATIONS OF MULTIPLE CYTOGENETIC HIGH-RISK ABNORMALITIES IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA
Binder, M.
Rajkumar, S. V.
Ketterling, R. P.
Dispenzieri, A.
Lacy, M. Q.
Gertz, M. A.
Buadi, F. K.
Hayman, S. R.
Hwa, Y. L.
Zeldenrust, S. R.
Lust, J. A.
Russell, S. J.
Leung, N.
Kapoor, P.
Go, R. S.
Gonsalves, W. I.
Kyle, R. A.
Kumar, S. K.
HAEMATOLOGICA, 2017, 102 : 107 - 107
[6] Prognostic Implications of Multiple Cytogenetic High-Risk Abnormalities in Patients with Newly Diagnosed Multiple Myeloma
Binder, Moritz
Rajkumar, S. Vincent
Ketterling, Rhett P.
Dispenzieri, Angela
Lacy, Martha Q.
Gertz, Morie A.
Buadi, Francis K.
Hayman, Suzanne R.
Hwa, Yi L.
Zeldenrust, Steven R.
Lust, John A.
Russell, Stephen J.
Leung, Nelson
Kapoor, Prashant
Go, Ronald S.
Gonsalves, Wilson I.
Kyle, Robert A.
Kumar, Shaji
BLOOD, 2016, 128 (22)
[7] Caution With Routine Use of Daratumumab for Newly Diagnosed High-Risk Multiple Myeloma
Mohyuddin, Ghulam Rehman
Abdallah, Al-Ola
McClune, Brian
JAMA ONCOLOGY, 2021, 7 (04) : 635 - 635
[8] Myeloma: management of the newly diagnosed high-risk patient
Dispenzieri, Angela
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2016, : 485 - 494
[9] Multiple myeloma: high-risk immunophenotypes identified
Nature Clinical Practice Oncology, 2008, 5 (9): : 496 - 496
[10] Association of thrombocytopenia with disease burden, high-risk cytogenetics, and survival in newly diagnosed multiple myeloma patients
Charalampous, Charalampos
Goel, Utkarsh
Kapoor, Prashant
Binder, Moritz
Buadi, Francis
Dingli, David
Dispenzieri, Angela
Fonder, Amie
Gertz, Morie
Gonsalves, Wilson
Hayman, Suzanne
Hobbs, Miriam
Hwa, Yi Lisa
Kourelis, Taxiarchis
Lacy, Martha
Leung, Nelson
Lin, Yi
Warsame, Rahma
Kyle, Robert
Rajkumar, Vincent
Kumar, Shaji
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S149 - S150

← 1 2 3 4 5 →